Other oximes similar to pralidoxime have been developed and tested, but none have made it into widespread use (Eddleston & Chowdhury, 2016)
Research suggests that MUFAs, such as those found in extra virgin olive oil and avocados are more potent triggers for GLP-1 secretion than saturated fats
Unlike semaglutide (Ozempic/Wegovy), which activates a single receptor (GLP-1), or tirzepatide (Mounjaro/Zepbound), which activates two (GLP-1 + GIP), retatrutide activates three metabolic receptors at once: GLP-1 slows gastric emptying, suppresses appetite, improves insulin response GIP additional insulin-sensitivity and appetite effects Glucagon boosts energy expenditure and lipolysis (this is the new mechanism) The glucagon component is what makes retatrutide unique
The oxidative stress caused by a decrease in GSH levels can then impact microglia function and potentially lead to a more pro-inflammatory M1 phenotype that has reduced -amyloid clearance capabilities (Vilhardt et al., 2017)
Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines